FTC Seeks Contempt Against Shkreli for Lifetime Ban
Tap title to read story
The Federal Trade Commission and seven states filed a contempt petition against Martin Shkreli, alleging he repeatedly violated a 2022 court order that barred him from the pharmaceutical industry for life.
Shkreli, released from prison in May two thousand twenty‑two for unrelated financial crimes, reportedly traded in over sixty pharmaceutical stocks and livestreamed commentary on companies such as Vyera Pharmaceuticals. The filing requests a judge to order Shkreli to divest any current holdings and pay a fine equal to his trading profits, with potential incarceration for future breaches.
FTC Commissioner Mark Meador emphasized that a lifetime ban must be enforced with commensurate penalties to deter future violations. The court order stems from a finding that Shkreli organized an anti‑competitive scheme to perpetuate his company Vyera Pharmaceuticals’ monopoly in the anti‑parasitic drug Daraprim, hiking its price from seventeen point five dollars per tablet to a whopping seven hundred
More context
Timeline
- 2017 — Shkreli convicted on securities fraud charges related to hedge funds
- 2018 — Sentenced to seven years in federal prison for securities fraud
- 2022 — Court order bans Shkreli from pharmaceutical industry for life
- 2022-05 — Released from prison with credit for time served
Why it matters
Immediate US impact: Potential fines and stock divestiture for Shkreli Possible long-term US impact: Reinforces enforcement of antitrust injunctions Most affected groups: Pharmaceutical investors and regulatory agencies Reader priority: Understand legal consequences for industry violations
Coverage notes
Center: Coverage from CNBC frames this as a developing news story: FTC Seeks Contempt Against Shkreli for Lifetime Ban. Reporting emphasizes verified facts, named sources, and near-term impact for readers. Left: Left-leaning desks covering the same development typically emphasize public impact, institutional accountability, and who is most affected. Right: Right-leaning desks covering the same development typically emphasize practical outcomes, market or security stakes, and institutional response.
Primary report
CNBC — FTC Seeks Contempt Against Shkreli for Lifetime Ban
Sources
JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.





